Financials
- Market Capitalization 25.71 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-51.3
市销率
2 326.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 235.49 USD | -0.45% | -0.53% | -18.19% | -47.97% | 31.51 B USD | ||
| 489 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 60.76 USD | -1.87% | -0.93% | +1.42% | +63.07% | 27.13 B USD | ||
| 510 | INSM Insmed Incorporated - Common Stock | 118.30 USD | -2.55% | -6.55% | +13.77% | -27.00% | 25.83 B USD | ||
| 511 | INCY Incyte Corporation - Common Stock | 124.43 USD | -2.59% | -3.60% | -3.45% | +48.40% | 25.22 B USD |